Dermata Therapeutics, Inc. (DRMA) AI Dilution Summary

DRMA's estimated cash was $6,285,907 as of 2026-08-18, rolled forward from $4,412,764 at 2026-06-30 against estimated monthly burn of $816,874. Its most recent capital raised was a private placement closed 2026-08-18, issuing 933,064 shares at $1.46 per share plus pre-funded and Series E and Series F warrants, for $3,200,000 net.